Edwards Lifesciences Corporation (EW) has seen multiple investment firms establish, increase, or sell their positions in its stock. Notably,
NINE MASTS CAPITAL Ltd,
Skandinaviska Enskilda Banken AB, and
Northwest & Ethical Investments L.P. have all grown their positions in the company. The
Employees Retirement System of Texas has acquired 69,100 shares, while
United Super Pty Ltd in Trustee for the Construction & Building Unions Superannuation Fund also increased its holdings.
BTIG reiterated a buy rating for the company and its stocks set new 12-month highs. However, there was a US$1.5b decrease in market cap last week. Elsewhere, the company anticipates
robust TAVR growth to drive Q3 earnings. Its updated
ESC/EACTS Guidelines for Severe Aortic Stenosis have been welcomed. The company is under FTC scrutiny, however, seeking to block its acquisition of
JenaValve. The inventory and sales growth provide an optimistic view of the company's ongoing progress despite some sell-offs from various investment companies.
Edwards Lifesciences Corp EW News Analytics from Thu, 24 Apr 2025 07:00:00 GMT to Sat, 29 Nov 2025 14:17:52 GMT -
Rating 5
- Innovation 3
- Information 8
- Rumor 7
